Skip to Content

Benign Prostatic Hyperplasia (BPH / Enlarged Prostate)

Benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate, is a natural part of aging for many men. The prostate surrounds the urethra (the tube that carries urine out of the body), and as it gradually enlarges, it can press on the urethra and interfere with normal urine flow.

While BPH is not cancerous, it can significantly affect sleep, daily activities, and overall quality of life. In more advanced cases, it can lead to complications such as urinary retention, infections, or bladder dysfunction.

At The Medical Group of New Jersey, our urology specialists provide comprehensive evaluation, personalized treatment options, and long-term management strategies to improve urinary function and prevent complications—while preserving comfort and quality of life.


Symptom Onset & Initial Evaluation

BPH symptoms typically develop slowly over time, which can make them easy to overlook at first. Many patients initially notice subtle changes in their urinary habits before symptoms become more disruptive.

Common symptoms include:

  • Weak or slow urine stream
  • Difficulty starting urination (hesitancy)
  • Frequent urination, especially at night (nocturia)
  • Urgency or sudden need to urinate
  • Feeling that the bladder does not fully empty
  • Dribbling at the end of urination

As symptoms progress, patients may experience interruptions in sleep, difficulty traveling, or anxiety about access to restrooms.

Evaluation

During your visit, your urologist will perform a thorough and respectful evaluation to understand both your symptoms and their impact on your daily life. This typically includes:

  • A detailed discussion of urinary patterns, symptom severity, and progression
  • Review of medications (some can worsen symptoms)
  • Assessment of fluid intake, caffeine, and alcohol use
  • Medical history, including diabetes or neurologic conditions
  • A focused physical exam, including a prostate exam

In many cases, a standardized symptom questionnaire (such as the IPSS score) is used to quantify severity and guide treatment decisions.


Diagnosis & Risk Assessment

The goal of diagnostic testing is to confirm BPH, rule out other conditions, and determine how significantly the prostate is affecting bladder function.

Laboratory Tests

  • Urinalysis: Checks for infection, blood, or other abnormalities that may mimic BPH symptoms
  • PSA (prostate-specific antigen): Helps assess prostate size and screen for prostate cancer risk
  • Kidney function tests (creatinine, BUN): Evaluated in patients with more severe symptoms or concern for urinary retention

Imaging (When Needed)

  • Ultrasound may be used to assess prostate size and bladder structure

Bladder & Flow Assessment

  • Post-void residual (bladder scan): Measures how much urine remains after urination
  • Uroflowmetry: Evaluates the strength and pattern of urine flow

Risk Assessment

Your urologist will assess:

  • Severity of symptoms and impact on quality of life
  • Degree of bladder obstruction
  • Risk of complications (urinary retention, infections, kidney effects)
  • PSA trends and prostate size

This information helps determine whether observation, medication, or procedural treatment is most appropriate.


Treatment & Long-Term Management

Treatment for BPH is highly individualized and based on symptom severity, lifestyle impact, and patient preference.

Watchful Waiting (Mild Symptoms)

For patients with mild symptoms, active monitoring may be appropriate. This includes regular follow-up visits, lifestyle adjustments, and symptom tracking.

Lifestyle & Behavioral Strategies

These are often the first step in management and may significantly improve symptoms:

  • Reducing fluid intake in the evening
  • Limiting caffeine and alcohol (which irritate the bladder)
  • Timed voiding (scheduled urination)
  • Double voiding to improve bladder emptying

Medications

Medications are commonly used and can be very effective:

  • Alpha-blockers (e.g., tamsulosin): Relax prostate and bladder neck muscles to improve urine flow
  • 5-alpha reductase inhibitors (e.g., finasteride): Gradually shrink prostate size over time

Minimally Invasive Procedures

For patients who do not respond well to medication or prefer a procedural option:

  • UroLift: Implants that hold prostate tissue away from the urethra
  • Rezūm therapy: Uses water vapor to reduce prostate tissue

These options typically offer quicker recovery and fewer side effects than traditional surgery.

Surgical Treatment

For more severe symptoms or complications:

  • Transurethral resection of the prostate (TURP): Removes excess prostate tissue
  • Laser procedures: Vaporize or remove obstructing tissue

Surgical options are highly effective for relieving obstruction and improving long-term outcomes.


Monitoring & Follow-Up

Ongoing follow-up is important to ensure symptoms remain controlled and to adjust treatment as needed.

During follow-up visits, your urologist will:

  • Reassess symptom severity and quality of life
  • Monitor response to medications or procedures
  • Repeat PSA testing when appropriate
  • Evaluate bladder function if symptoms change

Prognosis & Preventive Care

BPH is a progressive but highly manageable condition. With appropriate care, most patients experience significant symptom relief and improved quality of life.

Preventive care focuses on minimizing symptom progression and avoiding complications.

At The Medical Group of New Jersey, our goal is to help patients maintain independence, comfort, and confidence while preventing complications and preserving long-term urinary health.

Related Specialties